Europe — EMA

Oxaliplatino Kabi

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Kabi, is a platinum-based chemotherapy agent presented as a unknown/unknown for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatino Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a chemotherapy drug that acts on the colorectal cancer treatment pathway. - Metastatic colorectal cancer: Improves the overall treatment outcome by reducing tumor growth. - Adjuvant as the by ...

What are the side effects of Oxaliplatin?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →